Entheon Biomedical Corp. (CSE:ENBI)
Canada · Delayed Price · Currency is CAD 0.0900
0.00 (0.00%)
At close: Dec 5, 2025
Entheon Biomedical Company Description
Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Contact Details
Address: 999 West Broadway Vancouver, V5Z 1K5 Canada | |
| Phone | 604-562-3932 |
| Website | entheonbiomedical.com |
Stock Details
| Ticker Symbol | ENBI |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | December - November |
| Reporting Currency | CAD |
| ISIN Number | CA29383X2023 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Timothy Ko | President, Chief Executive Officer and Director |
| Soo-Whan Kim | Interim Chief Financial Officer |
| Dr. Brian E. Jahns Pharm.D. | Chief Business Officer |
| Kelly Pladson | Corporate Secretary |